PsychologyMedicineBiology

Kaifang Yao, C. Zhuo, Ximing Chen, Chao Li, Haitao Song, Jiatong Zou, H. Tian

2026.1.1Neurotherapeutics

DOI: 10.1016/j.neurot.2026.e00852

tlooto Summary

This study systematically delineated the overall genetic architecture of high-risk suicide syndrome through a post-genome-wide association study of this previously unmeasured latent phenotype.

Abstract

The genetic basis of traits associated with suicide risk remains poorly understood. We applied genomic structural equation modeling and integrated multiple post-genome-wide association study (GWAS) analysis strategies to identify potential causal single-nucleotide polymorphisms independent of known high-risk suicide syndrome GWAS variants, identifying four genome-wide-significant, putatively causal loci and six putatively causal genes. Additionally, we applied multiple transcriptome-wide association study (TWAS) methods at the tissue and cellular levels to fine-map susceptibility genes. Subsequently, we analyzed the key regulatory elements driving their expression. Next, we assessed genetic pleiotropy by evaluating genetic correlations between high-risk suicide syndrome and over one hundred common diseases. Furthermore, we constructed a polygenic risk score (PRS) from the summary statistics to quantify each chromosome's contribution to the associated genetic risk. Our study systematically delineated the overall genetic architecture of high-risk suicide syndrome through a GWAS of this previously unmeasured latent phenotype.

Citation format

YAO, Kaifang, et al. Mapping the genetic landscape of suicide risk: Insights from genomic SEM. Neurotherapeutics, 2026, 23(1): e00852.